Navigation Links
BioProcess International December 2012 Issue Now Available on the App Store for iPad and iPhone
Date:12/27/2012

New York, NY (PRWEB) December 27, 2012

BioProcess International (BPI) announces the publication of the December 2012 issue of BioProcess International on the App Store for iPad and iPhone. With this issue, BPI begins a new annual theme focusing on management and executive issues and brings back elements from the BioExecutive International publication. Also published on the App Store for December is an exclusive 48 page supplement covering Flexible Manufacturing.

The December Issue of BioProcess International includes the following articles:

Rapid Pharmaceutical Product Development: Getting Off the Critical Path and Onto the Right Path

A Framework for Process Knowledge Management: Reducing Risk and Realizing Value from Development to Manufacturing (Part 1 — Conceptual Framework)

Managing Cost Without Sacrificing Quality

A Decade of Success: The BPI Awards Honor Upstream, Downstream, and Manufacturing Achievements Over the Past 10 Years

Encouraging In-House Disclosures in a Whistleblower’s World

Understanding the Patient Journey: A Human-Factors Road Map to Delivery Device Development

Where’s the Viral Marketing for Spreading Info on Actual Viruses?

The Flexible Manufacturing Supplement includes the following articles:

Multiproduct Facility Design and Control for Biologics

Safety, Flexibility, and Efficiency: Preparing for the Future in Filling

Efficient Flexible Facilities for the 21st Century

Developing an Integrated, Continuous Bioprocessing Platform

Toward Flexible Hybrid Facilities of the Future

Establishing Strategic Supplier Partnerships to Facilitate Manufacturing Flexibility

Lean Six Sigma: A CMO’s Most Useful Traveling Companion

Biopharmaceuticals on Demand: Free from Traditional Restraints, China Reinvents Biomanufacturing

Download the BioProcess International mobile app by searching the app store for “BioProcess International” or visiting http://itunes.apple.com/us/app/bioprocess-international/id471903987?mt=8

About BioProcess International

BioProcess International™ (http://www.bioprocessintl.com) is a monthly, controlled-circulation magazine devoted to the development, scale-up, and manufacture of biotherapeutics and biodiagnostics. Each issue provides the global industrial biotherapeutic community with up-to-date, peer-reviewed information detailing the business, politics, ethics, applications, products, and services required to successfully drive biopharmaceuticals, vaccines, and biodiagnostics through the development and manufacturing process.

BioProcess International™ is part of the IBC Life Sciences Division of Informa, plc, a leading international provider of specialist information and services for the academic, professional and business communities. Informa offers a world-class portfolio of publications, events and data services for researchers, students, lecturers and professionals in the academic and scientific communities worldwide.

Subscribe today at http://inf-sub.halldata.com/site/INF000015BCland/init.do

Read the full story at http://www.prweb.com/releases/2012/12/prweb10275963.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. BioStorage Technologies Expands its Service Offering to Include Advanced Bioprocessing Solutions
2. UV Flu Technologies Expands Its International Footprint
3. Elsevier Supports International Crisis Aid Through Pillars of Hope Campaign
4. International Attendance for Networking and Education at Informex Beyond Manufacturing
5. Leading Investigator to Present Clinical Data on Generex Oral-lyn™ at International Diabetes Federation Meetings in Dubai
6. Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservations 2nd World Congress
7. First Free-Standing International Mesothelioma Research Laboratory Opens in Los Angeles
8. PAREXEL International to Present at J.P. Morgan Healthcare Conference
9. Elsevier Launches Bilingual International Nursing Skill Training and Management Platform: NursingChina.com
10. Senior Management of NeoStem and Its Subsidiaries Invited to Speak at Seventh International Conference on Cell Therapy for Cardiovascular Disease
11. First Product Candidate Moving Toward Commercialization as Result of Novus International and Verenium Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... February 27, 2017 A Europe-wide survey of ... researchers using animals in their research treat them with due care. ... and detailed analysis of the results indicates that there is a ... to put into practice the principles of the 3Rs (Refine, ... What ...
(Date:2/27/2017)... , Feb. 27, 2017 Fluxion Biosciences announced ... has been appointed as a Certified Service ... IsoFlux system will be used in Genetracer Biotech,s novel ... lung and colon cancer, with plans to move to ... is utilizing Fluxion,s IsoFlux System to isolate, recover, and ...
(Date:2/24/2017)... , ... February 24, 2017 , ... ... procedures can be safely completed in an ambulatory surgery center (ASC) with satisfactory ... procedures and previous two-year TDR studies. , Jake Lubinski, president of AxioMed, ...
(Date:2/24/2017)... SAN FRANCISCO , Feb. 24, 2017 ... that is developing a new category of therapeutics, announced ... trial of SB-030 in peripheral artery disease. The trial ... locally administered single-use therapeutic, in the reduction of restenosis ... reached this critical development milestone for SB-030," said ...
Breaking Biology Technology:
(Date:2/16/2017)... , Feb. 16, 2017  Genos, a community ... that it has received Laboratory Accreditation from the ... is presented to laboratories that meet stringent requirements ... scientifically rigorous processes. "Genos is committed ... laboratory practices. We,re honored to be receiving CAP ...
(Date:2/10/2017)... DUBLIN , Feb 10, 2017 ... PharmaBiotech,s new report "Personalized Medicine - Scientific and Commercial ... ... in personalized medicine. Diagnosis is integrated with therapy for selection ... emphasis on early detection and prevention of disease in modern ...
(Date:2/8/2017)... -- Report Highlights ... The global synthetic-biology market reached nearly $3.9 billion ... at a compound annual growth rate (CAGR) of 24.0% through ... markets for synthetic biology. - Analyses of global market trends, ... compound annual growth rates (CAGRs) through 2021. - Coverage of ...
Breaking Biology News(10 mins):